Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bar-Or

Showing results (171-180 of 410) with videos related to

Pageof 41
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2023
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitorAmit Bar-Or, Anne H Cross, Anthony L Cunningham, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 14, 2011
Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levelsIchiro Nakashima, Toshiyuki Takahashi, Bruce A C Cree, et al.
Lancet (London, England)|November 4, 2011
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Li, Peter A Calabresi, et al.
Trends in Molecular Medicine|February 20, 2021
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)Amit Bar-Or, Michael P Pender, Rajiv Khanna, et al.
Journal of Immunological Methods|August 30, 2022
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trialsIna Mexhitaj, Noha Lim, Jose I Fernandez-Velasco, et al.
Multiple Sclerosis and Related Disorders|November 14, 2019
Factors associated with health care utilization in pediatric multiple sclerosisRuth Ann Marrie, Julia O'Mahony, Colleen Maxwell, et al.
Journal of Clinical Immunology|August 25, 2022
Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18Julia E Rood, Ayman Rezk, Jennifer Pogoriler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2019
Exosome-enriched fractions from MS B cells induce oligodendrocyte deathJoyce A Benjamins, Liljana Nedelkoska, Hanane Touil, et al.
Neuroimage|December 11, 2019
Deep learning segmentation of orbital fat to calibrate conventional MRI for longitudinal studiesRobert A Brown, Dumitru Fetco, Robert Fratila, et al.
Journal of Neuroimmunology|March 31, 2012
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitroRobert P Lisak, Joyce A Benjamins, Liljana Nedelkoska, et al.
Pageof 41

Showing results (171-180 of 410) with videos related to

Sort By:
Pageof 41
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2023
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitorAmit Bar-Or, Anne H Cross, Anthony L Cunningham, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 14, 2011
Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levelsIchiro Nakashima, Toshiyuki Takahashi, Bruce A C Cree, et al.
Lancet (London, England)|November 4, 2011
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Li, Peter A Calabresi, et al.
Trends in Molecular Medicine|February 20, 2021
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)Amit Bar-Or, Michael P Pender, Rajiv Khanna, et al.
Journal of Immunological Methods|August 30, 2022
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trialsIna Mexhitaj, Noha Lim, Jose I Fernandez-Velasco, et al.
Multiple Sclerosis and Related Disorders|November 14, 2019
Factors associated with health care utilization in pediatric multiple sclerosisRuth Ann Marrie, Julia O'Mahony, Colleen Maxwell, et al.
Journal of Clinical Immunology|August 25, 2022
Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1β and IL-18Julia E Rood, Ayman Rezk, Jennifer Pogoriler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2019
Exosome-enriched fractions from MS B cells induce oligodendrocyte deathJoyce A Benjamins, Liljana Nedelkoska, Hanane Touil, et al.
Neuroimage|December 11, 2019
Deep learning segmentation of orbital fat to calibrate conventional MRI for longitudinal studiesRobert A Brown, Dumitru Fetco, Robert Fratila, et al.
Journal of Neuroimmunology|March 31, 2012
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitroRobert P Lisak, Joyce A Benjamins, Liljana Nedelkoska, et al.
Pageof 41